A profile of a telehealth-first longevity provider that earned a Milestone 2 award in the XPRIZE Healthspan competition and plans larger trials.
Key Takeaways
- AgelessRx has built its business on doing the opposite
- AgelessRx and its Stanford PhD-led research team were selected as one of ten Milestone 2 Awardees
- They will receive $1 million to advance their clinical trial toward the competition’s final phase